Jiang Chengfei, Li Ping, Ruan Xiangbo, Ma Yonghe, Kawai Kenji, Suemizu Hiroshi, Cao Haiming
Cardiovascular Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pathology Analysis Center, Central Institute for Experimental Animals, 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki 210-0821, Japan.
Cells. 2020 Nov 30;9(12):2566. doi: 10.3390/cells9122566.
Mouse is the most widely used animal model in biomedical research, but it remains unknown what causes the large number of differentially regulated genes between human and mouse livers identified in recent years. In this report, we aim to determine whether these divergent gene regulations are primarily caused by environmental factors or some of them are the result of cell-autonomous differences in gene regulation in human and mouse liver cells. The latter scenario would suggest that many human genes are subject to human-specific regulation and can only be adequately studied in a human or humanized system. To understand the similarity and divergence of gene regulation between human and mouse livers, we performed stepwise comparative analyses in human, mouse, and humanized livers with increased stringency to gradually remove the impact of factors external to liver cells, and used bioinformatics approaches to retrieve gene networks to ascertain the regulated biological processes. We first compared liver gene regulation by fatty liver disease in human and mouse under the condition where the impact of genetic and gender biases was minimized, and identified over 50% of all commonly regulated genes, that exhibit opposite regulation by fatty liver disease in human and mouse. We subsequently performed more stringent comparisons when a single specific transcriptional or post-transcriptional event was modulated in vitro or vivo or in liver-specific humanized mice in which human and mouse hepatocytes colocalize and share a common circulation. Intriguingly and strikingly, the pattern of a high percentage of oppositely regulated genes persists under well-matched conditions, even in the liver of the humanized mouse model, which represents the most closely matched in vivo condition for human and mouse liver cells that is experimentally achievable. Gene network analyses further corroborated the results of oppositely regulated genes and revealed substantial differences in regulated biological processes in human and mouse cells. We also identified a list of regulated lncRNAs that exhibit very limited conservation and could contribute to these differential gene regulations. Our data support that cell-autonomous differences in gene regulation might contribute substantially to the divergent gene regulation between human and mouse livers and there are a significant number of biological processes that are subject to human-specific regulation and need to be carefully considered in the process of mouse to human translation.
小鼠是生物医学研究中使用最广泛的动物模型,但近年来在人类和小鼠肝脏中鉴定出的大量差异调节基因的成因仍不清楚。在本报告中,我们旨在确定这些不同的基因调控主要是由环境因素引起的,还是其中一些是人类和小鼠肝细胞基因调控中细胞自主性差异的结果。后一种情况表明,许多人类基因受到人类特异性调控,只能在人类或人源化系统中进行充分研究。为了了解人类和小鼠肝脏之间基因调控的异同,我们在人类、小鼠和人源化肝脏中进行了逐步比较分析,并提高了严格性,以逐渐消除肝细胞外部因素的影响,并使用生物信息学方法检索基因网络,以确定受调控的生物学过程。我们首先在将遗传和性别偏差的影响降至最低的条件下,比较了人类和小鼠中脂肪肝疾病对肝脏基因的调控,确定了所有共同调控基因的50%以上,这些基因在人类和小鼠中受脂肪肝疾病调控时表现出相反的调控。随后我们进行了更严格的比较,即在体外、体内或肝脏特异性人源化小鼠(其中人类和小鼠肝细胞共定位并共享共同循环)中调节单个特定转录或转录后事件时。有趣且引人注目的是,即使在人源化小鼠模型的肝脏中,即在实验上可实现的人类和小鼠肝细胞最匹配的体内条件下,在匹配良好的条件下仍存在高比例反向调控基因的模式。基因网络分析进一步证实了反向调控基因的结果,并揭示了人类和小鼠细胞中受调控的生物学过程存在实质性差异。我们还鉴定出了一系列受调控的lncRNA,它们的保守性非常有限,可能导致这些差异基因调控。我们的数据支持基因调控中的细胞自主性差异可能在很大程度上导致人类和小鼠肝脏之间的基因调控差异,并且有大量生物学过程受到人类特异性调控,在从小鼠到人类的转化过程中需要仔细考虑。